Your browser doesn't support javascript.
loading
Erythroderma in Adult-Onset Still's Disease Alleviated After Tocilizumab Therapy: A Case Report.
Zhang, Li-Na; Zhao, Zheng; Song, Juan-Juan; Lin, Bo-Zhi; Zhang, Tong.
Affiliation
  • Zhang LN; Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, CHN.
  • Zhao Z; Department of Dermatology, Peking University International Hospital, Beijing, CHN.
  • Song JJ; Department of Nuclear Medicine, Peking University International Hospital, Beijing, CHN.
  • Lin BZ; Department of Clinical Laboratory, Peking University International Hospital, Beijing, CHN.
  • Zhang T; Department of Pathology, Peking University International Hospital, Beijing, CHN.
Cureus ; 16(5): e60372, 2024 May.
Article in En | MEDLINE | ID: mdl-38883073
ABSTRACT
Erythroderma, also known as exfoliative dermatitis, is a rarely reported atypical cutaneous manifestation of adult-onset Still's disease (AOSD). We present the case of erythroderma in association with AOSD that was steroid dependent and responded to tocilizumab therapy. Skin rash, pruritis, and related laboratory findings were significantly improved upon the addition of tocilizumab, while prednisolone was successfully tapered to an ever-lowest maintenance level. To our knowledge, this is the first to report the sole therapeutic effect of tocilizumab in erythroderma related to AOSD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article